2405-8521

Papillomavirus Research

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 244 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact244 DOIs
2

Attach ORCID iDs across 227 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact227 DOIs
3

Deposit reference lists for 44 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact44 DOIs

DOIs for this ISSN

Showing the top 5 of 244 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Validation of the vaccine conspiracy beliefs scale (10.1016/j.pvr.2016.09.001)
Abstract ORCID
118.55 234
2 European guidelines for quality assurance in cervical cancer… (10.1016/j.pvr.2015.06.006)
Abstract ORCID
116.01 208
3 Therapeutic vaccines for high-risk HPV-associated diseases (10.1016/j.pvr.2017.12.006)
Abstract ORCID
114.28 192
4 Towards the global elimination of cervical cancer (10.1016/j.pvr.2019.100170)
Abstract ORCID
112.40 176
5 No association between HPV vaccine and reported post-vaccina… (10.1016/j.pvr.2018.02.002)
Abstract ORCID
111.65 170
6 The feminization of HPV: How science, politics, economics an… (10.1016/j.pvr.2017.04.004)
Abstract ORCID
109.93 157
7 IPVS statement moving towards elimination of cervical cancer… (10.1016/j.pvr.2018.02.003)
Abstract References ORCID
103.52 23
8 Is one dose of human papillomavirus vaccine as effective as… (10.1016/j.pvr.2019.100177)
Abstract ORCID
101.06 104
9 Time to change perspectives on HPV in oropharyngeal cancer.… (10.1016/j.pvr.2017.05.002)
Abstract ORCID
99.78 98
10 Refining our understanding of cervical neoplasia and its cel… (10.1016/j.pvr.2019.04.005)
Abstract ORCID
99.34 96
11 Deep sequencing of HPV16 genomes: A new high-throughput tool… (10.1016/j.pvr.2015.05.004)
Abstract ORCID
97.71 89
12 Human papillomavirus 16 sub-lineage dispersal and cervical c… (10.1016/j.pvr.2019.02.001)
Abstract ORCID
96.72 85
13 Estimation of the epidemiological burden of HPV-related anog… (10.1016/j.pvr.2015.06.003)
Abstract ORCID
95.95 82
14 Barriers, facilitators, and potential strategies for increas… (10.1016/j.pvr.2017.11.003)
Abstract ORCID
94.88 78
15 HPV and skin carcinogenesis (10.1016/j.pvr.2019.04.003)
Abstract ORCID
93.46 73
16 HPV vaccination of immunocompromised hosts (10.1016/j.pvr.2017.06.002)
Abstract ORCID
92.87 71
17 Need for expanded HPV genotyping for cervical screening (10.1016/j.pvr.2016.05.004)
Abstract ORCID
91.63 67
18 Contribution of Human papillomavirus in neuroendocrine tumor… (10.1016/j.pvr.2018.03.005)
Abstract ORCID
91.63 67
19 Human papillomavirus (HPV) vaccine coverage achievements in… (10.1016/j.pvr.2017.09.001)
Abstract ORCID
90.98 65
20 Effectiveness of less than three doses of quadrivalent human… (10.1016/j.pvr.2015.05.005)
Abstract ORCID
90.65 64
21 School-based human papillomavirus vaccination program for in… (10.1016/j.pvr.2019.100189)
Abstract ORCID
90.65 64
22 Knowledge, attitudes, and perception towards human papilloma… (10.1016/j.pvr.2016.06.001)
Abstract ORCID
89.97 62
23 Human papillomavirus (HPV) perinatal transmission and risk o… (10.1016/j.pvr.2016.07.001)
Abstract ORCID
89.97 62
24 Modulation of antigen presenting cell functions during chron… (10.1016/j.pvr.2017.08.002)
Abstract ORCID
89.62 61
25 HPV vaccination in HIV infection (10.1016/j.pvr.2019.100174)
Abstract ORCID
89.27 60
26 HPV-FRAME: A consensus statement and quality framework for m… (10.1016/j.pvr.2019.100184)
Abstract ORCID
89.27 60
27 Knowledge about HPV and vaccination among young adult men an… (10.1016/j.pvr.2019.03.003)
Abstract ORCID
88.91 59
28 Molecular events leading to HPV-induced high grade neoplasia (10.1016/j.pvr.2016.04.003)
Abstract ORCID
88.17 57
29 The cervical microbiota in reproductive-age South African wo… (10.1016/j.pvr.2019.04.006)
Abstract ORCID
87.41 55
30 Surgical staging identified false HPV-negative cases in a la… (10.1016/j.pvr.2017.10.003)
Abstract ORCID
87.02 54
31 Overcoming barriers in HPV vaccination and screening program… (10.1016/j.pvr.2017.07.001)
Abstract ORCID
86.62 53
32 When and how often to screen for cervical cancer in three lo… (10.1016/j.pvr.2015.05.003)
Abstract ORCID
86.21 52
33 Long-term immunogenicity, effectiveness, and safety of nine-… (10.1016/j.pvr.2020.100203)
Abstract ORCID
86.21 52
34 Are dental providers the next line of HPV-related prevention… (10.1016/j.pvr.2018.03.002)
Abstract ORCID
84.95 49
35 Prevalence, incidence, and natural history of HPV infection… (10.1016/j.pvr.2020.100202)
Abstract ORCID
84.06 47
36 “We brought our culture here with us”: A qualitative study o… (10.1016/j.pvr.2018.12.003)
Abstract ORCID
83.60 46
37 Role of DNA methylation in HPV associated lesions (10.1016/j.pvr.2019.03.005)
Abstract ORCID
82.66 44
38 Influencers and preference predictors of HPV vaccine uptake… (10.1016/j.pvr.2018.03.007)
Abstract ORCID
82.17 43
39 The role of healthcare providers in HPV vaccination programs… (10.1016/j.pvr.2019.100183)
Abstract ORCID
82.17 43
40 Human papillomavirus 16 (HPV16) enhances tumor growth and ca… (10.1016/j.pvr.2015.08.001)
Abstract ORCID
81.67 42
41 Time and temperature dependent analytical stability of dry-c… (10.1016/j.pvr.2018.04.005)
Abstract ORCID
81.67 42
42 Malignant transformation of canine oral papillomavirus (CPV1… (10.1016/j.pvr.2018.10.007)
Abstract ORCID
81.67 42
43 Statewide analysis of missed opportunities for human papillo… (10.1016/j.pvr.2016.06.002)
Abstract ORCID
81.16 41
44 Extracellular events impacting human papillomavirus infectio… (10.1016/j.pvr.2019.04.009)
Abstract ORCID
81.16 41
45 Prevalence and risk factors associated with high-grade anal… (10.1016/j.pvr.2016.05.003)
Abstract ORCID
80.10 39
46 False positive cervical HPV screening test results (10.1016/j.pvr.2019.04.012)
Abstract ORCID
80.10 39
47 What works for human papillomavirus vaccine introduction in… (10.1016/j.pvr.2017.06.003)
Abstract ORCID
79.55 38
48 Syndemic synergy of HPV and other sexually transmitted patho… (10.1016/j.pvr.2017.10.004)
Abstract ORCID
79.55 38
49 Infection and vaccine-induced HPV-specific antibodies in cer… (10.1016/j.pvr.2019.100185)
Abstract ORCID
78.41 36
50 Intra-host sequence variability in human papillomavirus (10.1016/j.pvr.2018.04.006)
Abstract ORCID
77.82 35